Vincent van der Noort

24PUBLICATIONS
128CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Microbial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jan 08, 2026
Stage I non-small cell lung cancer: improving patient selection for minimally invasive lobectomy or stereotactic ablative radiotherapy based on clinical characteristics.

Julianne Cynthia de Ruiter, Vincent van der Noort, Judi Nani Annet van Diessen

|Dec 24, 2025
The effect of pirfenidone on disease progression in asbestosis patients: a real-world Dutch cohort study.

Illaa Smesseim, Anne E Wind, Jelle R Miedema

|Oct 08, 2025
Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.

Sabine E Breukers, Joleen J H Traets, Stan W van Dijk

|Oct 01, 2025
Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol.

Karlijn Verkerk, Soemeya F Haj Mohammad, Laurien J Zeverijn

|Sep 25, 2025
Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade Therapy.

Iris L Mimpen, Thomas W Battaglia, Miguel Parra-Martinez

Pageof 4